Search Results - "Canonica, G."

Allergic rhinitis by Bousquet, Jean, Anto, Josep M., Bachert, Claus, Baiardini, Ilaria, Bosnic-Anticevich, Sinthia, Walter Canonica, G., Melén, Erik, Palomares, Oscar, Scadding, Glenis K., Togias, Alkis, Toppila-Salmi, Sanna

“…Allergic rhinitis (AR) is caused by immunoglobulin E (IgE)-mediated reactions to inhaled allergens and is one of the most common chronic conditions globally…”
Get full text

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision by Brożek, Jan L., MD, PhD, Bousquet, Jean, MD, PhD, Baena-Cagnani, Carlos E., MD, Bonini, Sergio, MD, Canonica, G. Walter, MD, Casale, Thomas B., MD, van Wijk, Roy Gerth, MD, PhD, Ohta, Ken, MD, PhD, Zuberbier, Torsten, MD, Schünemann, Holger J., MD, PhD, MSc

“…Background Allergic rhinitis represents a global health problem affecting 10% to 20% of the population. The Allergic Rhinitis and its Impact on Asthma (ARIA)…”
Get full text

Disease-modifying anti-asthmatic drugs by Lommatzsch, Marek, Brusselle, Guy G, Canonica, G Walter, Jackson, David J, Nair, Parameswaran, Buhl, Roland, Virchow, Johann Christian

Get full text

Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials by Bachert, Claus, Han, Joseph K, Desrosiers, Martin, Hellings, Peter W, Amin, Nikhil, Lee, Stella E, Mullol, Joaquim, Greos, Leon S, Bosso, John V, Laidlaw, Tanya M, Cervin, Anders U, Maspero, Jorge F, Hopkins, Claire, Olze, Heidi, Canonica, G Walter, Paggiaro, Pierluigi, Cho, Seong H, Fokkens, Wytske J, Fujieda, Shigeharu, Zhang, Mei, Lu, Xin, Fan, Chunpeng, Draikiwicz, Steven, Kamat, Siddhesh A, Khan, Asif, Pirozzi, Gianluca, Patel, Naimish, Graham, Neil M H, Ruddy, Marcella, Staudinger, Heribert, Weinreich, David, Stahl, Neil, Yancopoulos, George D, Mannent, Leda P

“…Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) generally have a high symptom burden and poor health-related quality of life, often requiring…”
Get full text

Biologics and airway remodeling in severe asthma by Varricchi, Gilda, Ferri, Sebastian, Pepys, Jack, Poto, Remo, Spadaro, Giuseppe, Nappi, Emanuele, Paoletti, Giovanni, Virchow, Johann Christian, Heffler, Enrico, Canonica, Walter G.

“…Asthma is a chronic inflammatory airway disease resulting in airflow obstruction, which in part can become irreversible to conventional therapies, defining the…”
Get full text

Handling of allergen immunotherapy in the COVID‐19 pandemic: An ARIA‐EAACI statement by Pfaar, Oliver, Klimek, Ludger, Jutel, Marek, Akdis, Cezmi, Bousquet, Jean, Akdis, Mübeccel, Bachert, Claus, Agache, Ioana, Ansotegui, Ignacio, Bedbrook, Anna, Bosnic‐Anticevich, Sinthia, Canonica, Giorgio W., Chivato, Tomas, Cruz, Alvaro A., Czarlewski, Wienia, Del Giacco, Stefano, Du, Hui, Fonseca, Joao A., Gao, Yadong, Haahtela, Tari, Hoffmann‐Sommergruber, Karin, Ivancevich, Juan‐Carlos, Khaltaev, Nikolai, Knol, Edward F., Kuna, Piotr, Larenas‐Linnemann, Desiree, Melen, Erik, Mullol, Joaquim, Naclerio, Robert, Ohta, Ken, Okamoto, Yoshitaka, O’Mahony, Liam, Onorato, Gabrielle L, Papadopoulos, Nikos G., Pawankar, Ruby, Samolinski, Boleslaw, Schwarze, Jurgen, Toppila‐Salmi, Sanna, Shamji, Mohamed H., Teresa Ventura, Maria, Valiulis, Arunas, Yorgancioglu, Arzu, Matricardi, Paolo, Zuberbier, Torsten

“…The current COVID‐19 pandemic influences many areas of social life, medical treatments and the way allergy is performed. Allergen‐specific immunotherapy (AIT)…”
Get full text

Characterization of Severe Asthma Worldwide: Data From the International Severe Asthma Registry by Wang, Eileen, Wechsler, Michael E, Tran, Trung N, Heaney, Liam G, Jones, Rupert C, Menzies-Gow, Andrew N, Busby, John, Jackson, David J, Pfeffer, Paul E, Rhee, Chin Kook, Cho, You Sook, Canonica, G Walter, Heffler, Enrico, Gibson, Peter G, Hew, Mark, Peters, Matthew, Harvey, Erin S, Alacqua, Marianna, Zangrilli, James, Bulathsinhala, Lakmini, Carter, Victoria A, Chaudhry, Isha, Eleangovan, Neva, Hosseini, Naeimeh, Murray, Ruth B, Price, David B

“…Clinical characteristics of the international population with severe asthma are unknown. Intercountry comparisons are hindered by variable data collection…”
Get full text

Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID‐ERD: Results from two randomized placebo‐controlled phase 3 trials by Mullol, Joaquim, Laidlaw, Tanya M., Bachert, Claus, Mannent, Leda P., Canonica, G. Walter, Han, Joseph K., Maspero, Jorge F., Picado, Cesar, Daizadeh, Nadia, Ortiz, Benjamin, Li, Yongtao, Ruddy, Marcella, Laws, Elizabeth, Amin, Nikhil

“…Background About one‐tenth of patients with difficult‐to‐treat chronic rhinosinusitis with nasal polyps (CRSwNP) have comorbid non‐steroidal anti‐inflammatory…”
Get full text

Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper by Pfaar, O, Demoly, P, Gerth van Wijk, R, Bonini, S, Bousquet, J, Canonica, G W, Durham, S R, Jacobsen, L, Malling, H J, Mösges, R, Papadopoulos, N G, Rak, S, Rodriguez del Rio, P, Valovirta, E, Wahn, U, Calderon, M A

“…Allergen immunotherapy (AIT) has been thoroughly documented in randomized controlled trials (RCTs). It is the only immune-modifying and causal treatment…”
Get full text

Face masks, respiratory patients and COVID-19 by Soriano, Joan B, Anzueto, Antonio, Bosnic Anticevich, Sinthia, Kaplan, Alan, Miravitlles, Marc, Usmani, Omar, Papadopoulos, Nikolaos G, Puggioni, Francesca, Canonica, G Walter, Roche, Nicolas

“…Several countries have applied exemptions of respiratory patients on the compulsory use of face masks indoors and outdoors during the coronavirus disease 2019…”
Get full text

EAACI/GA²LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria by Zuberbier, T, Asero, R, Bindslev-Jensen, C, Walter Canonica, G, Church, M.K, Giménez-Arnau, A, Grattan, C.E.H, Kapp, A, Merk, H.F, Rogala, B, Saini, S, Sánchez-Borges, M, Schmid-Grendelmeier, P, Schünemann, H, Staubach, P, Vena, G.A, Wedi, B, Maurer, M

“…This guideline, together with its sister guideline on the management of urticaria [Zuberbier T, Asero R, Bindslev-Jensen C, Canonica GW, Church MK,…”
Get full text

Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE by Humbert, M., Beasley, R., Ayres, J., Slavin, R., Hébert, J., Bousquet, J., Beeh, K.‐M., Ramos, S., Canonica, G. W., Hedgecock, S., Fox, H., Blogg, M., Surrey, K.

“…Background:  Patients with severe persistent asthma who are inadequately controlled despite Global Initiative for Asthma (GINA) 2002 step 4 therapy are a…”
Get full text

Minimal persistent inflammation in allergic rhinitis: implications for current treatment strategies by Canonica, G. W., Compalati, E.

“…Summary Patients with allergic rhinitis have traditionally been placed into ‘seasonal’ and ‘perennial’ categories, which do not account for the subclinical…”
Get full text

The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update by Zuberbier, T, Aberer, W, Asero, R, Bindslev-Jensen, C, Brzoza, Z, Canonica, G W, Church, M K, Ensina, L F, Giménez-Arnau, A, Godse, K, Gonçalo, M, Grattan, C, Hebert, J, Hide, M, Kaplan, A, Kapp, A, Abdul Latiff, A H, Mathelier-Fusade, P, Metz, M, Nast, A, Saini, S S, Sánchez-Borges, M, Schmid-Grendelmeier, P, Simons, F E R, Staubach, P, Sussman, G, Toubi, E, Vena, G A, Wedi, B, Zhu, X J, Maurer, M

“…This guideline is the result of a systematic literature review using the 'Grading of Recommendations Assessment, Development and Evaluation' (GRADE)…”
Get full text

Patient‐reported outcome measures in birch pollen allergic patients treated with sublingual immunotherapy reflect real life by Bahbah, Farah, Gentil, Catherine, Sousa‐Pinto, Bernardo, Canonica, G. Walter, Devillier, Philippe, Pfaar, Oliver, Bousquet, Jean

Get full text

Adherence to pharmacological treatment and specific immunotherapy in allergic rhinitis by Passalacqua, G., Baiardini, I., Senna, G., Canonica, G. W.

“…Summary The term compliance simply indicates how much doses of the prescribed medication are taken, whereas the term adherence implies also an agreement…”
Get full text

Practical guide to skin prick tests in allergy to aeroallergens by Bousquet, J., Heinzerling, L., Bachert, C., Papadopoulos, N. G., Bousquet, P. J., Burney, P. G., Canonica, G. W., Carlsen, K. H., Cox, L., Haahtela, T., Lodrup Carlsen, K. C., Price, D., Samolinski, B., Simons, F. E. R., Wickman, M., Annesi-Maesano, I., Baena-Cagnani, C. E., Bergmann, K. C., Bindslev-Jensen, C., Casale, T. B., Chiriac, A., Cruz, A. A., Dubakiene, R., Durham, S. R., Fokkens, W. J., Gerth-van-Wijk, R., Kalayci, O., Kowalski, M. L., Mari, A., Mullol, J., Nazamova-Baranova, L., O'Hehir, R. E., Ohta, K., Panzner, P., Passalacqua, G., Ring, J., Rogala, B., Romano, A., Ryan, D., Schmid-Grendelmeier, P., Todo-Bom, A., Valenta, R., Woehrl, S., Yusuf, O. M., Zuberbier, T., Demoly, P.

“…To cite this article: Bousquet J, Heinzerling L, Bachert C, Papadopoulos NG, Bousquet PJ, Burney PG, Canonica GW, Carlsen KH, Cox L, Haahtela T, Lodrup Carlsen…”
Get full text

The contribution of digital health to net zero patient care in allergic diseases: From concept to practice by Bousquet, Jean, Haahtela, Tari, Anto, Josep M., Haveri, Hanna, Puggioni, Francesca, Makela, Mika, Bourret, Rodolphe, Canonica, G. Walter

Get full text

Guideline recommendations on the use of allergen immunotherapy in house dust mite allergy: time for a change? by Calderón, Moisés A., MD, PhD, Bousquet, Jean, MD, Canonica, G. Walter, MD, Cardell, Lars-Olaf, MD, PhD, Fernandez de Rojas, Dolores Hernandez, MD, PhD, Kleine-Tebbe, Jörg, MD, Demoly, Pascal, MD, PhD

“…Abstract Guidelines on the treatment of asthma, allergic rhinitis (AR) and allergen immunotherapy (AIT) lack recommendations for house dust mite (HDM) allergy…”
Get full text

ARIA‐EAACI statement on severe allergic reactions to COVID‐19 vaccines – An EAACI‐ARIA Position Paper by Klimek, Ludger, Jutel, Marek, Akdis, Cezmi A., Bousquet, Jean, Akdis, Mübeccel, Torres, Maria J, Agache, Ioana, Canonica, G. Walter, Del Giacco, Stefano, O'Mahony, Liam, Shamji, Mohamed H., Schwarze, Jürgen, Untersmayr, Eva, Ring, Johannes, Bedbrook, Anna, Worm, Margitta, Zuberbier, Torsten, Knol, Edward, Hoffmann‐Sommergruber, Karin, Chivato, Tomás

“…Further to the approval of the Coronavirus disease 2019 (COVID‐19) vaccine BNT162b2, several severe anaphylaxis cases occured within the first few days of…”
Get full text